Therefore, precision therapeutic strategies that promote heightened JNK activation may augment TRAIL-mediated apoptosis in colon cancer and other malignancies that exhibit sensitivity to TRAIL [13,14]. Here, TNFSF10 is linked to malignant colon neoplasm.